VitriVax
Boulder, US · Delaware corporation · 3 known investors
Founders & leadership
TR
Theodore RandolphFounder
RC
Romulo ColindresExecutive
Board
GR
Glenn RockmanBoard director
RL
Rene LorenzBoard director
LB
Louise BradyBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$29.4M disclosed across 1 round · 2025
▶$29.4MraisedNov 2025 · 83 investors · BiotechnologyRule 506(b)
▶$29.4MraisedNov 2025 · 83 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Glenn RockmanDirector
- Rene LorenzDirector
- Louise BradyDirector
- Theodore RandolphDirector
- Romulo ColindresExecutive Officer, Director, Promoter
- Offering amount
- $37.1M
- Amount sold
- $29.4M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded VitriVax?
- VitriVax was founded by Theodore Randolph.
- Who are VitriVax's investors?
- VitriVax's investors include Buff Gold Ventures, CU Healthcare Innovation Fund, RA Capital.
- How much funding has VitriVax raised?
- VitriVax has disclosed $29.4M raised across 1 round.
- Where is VitriVax headquartered?
- VitriVax is headquartered in Boulder, US.